4TMA image
Deposition Date 2014-05-31
Release Date 2014-07-23
Last Version Date 2023-09-27
Entry Detail
PDB ID:
4TMA
Title:
Crystal structure of gyrase bound to its inhibitor YacG
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.30 Å
R-Value Free:
0.28
R-Value Work:
0.24
R-Value Observed:
0.24
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:DNA gyrase subunit A
Chain IDs:A, C, E, G
Chain Length:525
Number of Molecules:4
Biological Source:Escherichia coli
Polymer Type:polypeptide(L)
Molecule:DNA gyrase subunit B
Mutations:F74Y
Chain IDs:B, D, F, H
Chain Length:417
Number of Molecules:4
Biological Source:Escherichia coli
Polymer Type:polypeptide(L)
Molecule:DNA gyrase inhibitor YacG
Gene (Uniprot):yacG
Chain IDs:I, J, K, L
Chain Length:65
Number of Molecules:4
Biological Source:Escherichia coli
Ligand Molecules
Primary Citation
Direct control of type IIA topoisomerase activity by a chromosomally encoded regulatory protein.
Genes Dev. 28 1485 1497 (2014)
PMID: 24990966 DOI: 10.1101/gad.241984.114

Abstact

Precise control of supercoiling homeostasis is critical to DNA-dependent processes such as gene expression, replication, and damage response. Topoisomerases are central regulators of DNA supercoiling commonly thought to act independently in the recognition and modulation of chromosome superstructure; however, recent evidence has indicated that cells tightly regulate topoisomerase activity to support chromosome dynamics, transcriptional response, and replicative events. How topoisomerase control is executed and linked to the internal status of a cell is poorly understood. To investigate these connections, we determined the structure of Escherichia coli gyrase, a type IIA topoisomerase bound to YacG, a recently identified chromosomally encoded inhibitor protein. Phylogenetic analyses indicate that YacG is frequently associated with coenzyme A (CoA) production enzymes, linking the protein to metabolism and stress. The structure, along with supporting solution studies, shows that YacG represses gyrase by sterically occluding the principal DNA-binding site of the enzyme. Unexpectedly, YacG acts by both engaging two spatially segregated regions associated with small-molecule inhibitor interactions (fluoroquinolone antibiotics and the newly reported antagonist GSK299423) and remodeling the gyrase holoenzyme into an inactive, ATP-trapped configuration. This study establishes a new mechanism for the protein-based control of topoisomerases, an approach that may be used to alter supercoiling levels for responding to changes in cellular state.

Legend

Protein

Chemical

Disease

Primary Citation of related structures